Ebol, Gregorio M.
HRN: 24-38-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/12/2024
LEVOFLOXACIN 500MG (TAB)
02/12/2024
02/18/2024
PO
500mg
OD
CAP-MR; S/P CTT Right For Pleural Effusion
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes